Evaluation of renal and hematologic toxicities of 212Pb-VMT-alpha-NET to inform the safety of alpha-particle therapy for neuroendocrine tumors

被引：0
|
作者：
Lee, D. [1 ]
Li, M. [2 ]
Liu, D. [3 ]
Baumhover, N. [1 ]
Sagastume, E. A. [2 ]
Marks, B. [2 ]
Graves, S. A. [1 ]
Zepeda-Orozco, D. [4 ]
Johnson, F. L. [2 ]
Menda, Y. [1 ]
Bushnell, D. L. [1 ]
Schultz, M. K. [1 ]
机构：
[1] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA
[2] Viewpoint Mol Targeting Inc, Coralville, IA USA
[3] Univ Iowa, Stead Family Dept Pediat, Iowa City, IA USA
[4] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH USA
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2021年 / 33卷
关键词：
prrt; alpha-particle therapy; pb-212; vmt-alpha-net; toxicity;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
K23
引用
收藏
页码：190 / 190
页数：1
相关论文
共 23 条
  • [1] Preclinical evaluation of 212Pb-based alpha-particle therapy for neuroendocrine tumors: dosimetry and potential toxicities
    Lee, Dongyoul
    Graves, Stephen
    Liu, Dijie
    Wen, Hsiang
    Zepeda-Orozco, Diana
    Madsen, Mark
    Walsh, Susan
    Watkins, G.
    Menda, Yusuf
    Schultz, Michael
    Bushnell, David
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [2] 212Pb-VMT-I±-NET Targeted Alpha Therapy in Metastatic Neuroendocrine Tumors: First in Human study on Safety and Efficacy
    Sen, Ishita
    Malik, Dharmender
    Thakral, Parul
    Schultz, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [3] A Phase I/IIa of [212Pb]VMT-i i-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
    Prasad, Vikas
    Trikalinos, Nikolaos
    Hanna, Alaa
    Johnson, Frances
    Puhlmann, Markus
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [4] Dosimetry and Potential Toxicities of 212Pb-DOTATOC in a Preclinical Model: Towards Personalized Dosimetry Based Alpha-Particle Therapy for Neuroendocrine Tumors
    Lee, Dongyoul
    Graves, Stephen
    Liu, Dijie
    Wen, Hsiang
    Zepeda-Orozco, Diana
    Madsen, Mark
    Walsh, Susan
    Watkins, G.
    Menda, Yusuf
    Schultz, Michael
    Bushnell, David
    PANCREAS, 2020, 49 (03) : 475 - 475
  • [5] Structurally-Optimized Peptide VMT-Alpha-NET Enhances the Efficacy of SSTR2-Targeted Alpha-Particle Therapy for Neuroendocrine Tumors
    Lee, D.
    Li, M.
    Baumhover, N.
    Liu, D.
    Sagastume, E.
    Marks, B.
    Graves, S. A.
    Zepeda-Orozco, D.
    Walsh, S. A.
    Menda, Y.
    Bushnell, D. L.
    Schultz, M. K.
    NEUROENDOCRINOLOGY, 2020, 110 : 262 - 262
  • [6] Targeted alpha therapy of [212Pb]VMT-α-NET in metastatic neuroblastoma model
    Liu, Dijie
    Dai, Zhiming
    Ewald, Jordan
    Cagle, Brianna
    Li, Mengshi
    Hanna, Alaa
    Sagastume, Edwin
    Robles-Planells, Claudia
    Rodman, Samuel
    Johnson, Frances
    Zepeda-Orozco, Diana
    Schultz, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [7] Early results of 212Pb-VMT-α-NET Targeted Alpha Therapy in Metastatic Gastro-entero-pancreatic Neuroendocrine Tumors: First in Human Clinical Experience on Safety and Efficacy
    Malik, D.
    Sen, I.
    Thakral, P.
    Das, S.
    Schultz, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S313 - S313
  • [8] Image guided evaluation of 212Pb-VMT-a-NET in metastatic Neuroendocrine tumors: Bio distribution and Dosimetry
    Malik, D.
    Thakral, P.
    Rana, N.
    Singh, N.
    Koley, M.
    Gupta, J.
    Thakrani, D.
    Kapoor, S.
    Das, S. S.
    Schultz, M.
    Sen, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S803 - S804
  • [9] Interim results of 212Pb-VMT-a-NET Targeted Alpha Therapy in Metastatic Gastro-entero-pancreatic Neuroendocrine Tumors: First In-human Clinical Results on Safety and Efficacy
    Malik, D.
    Sen, I.
    Thakral, P.
    Das, S. S.
    Kapoor, S.
    Kumari, J.
    Singh, N.
    Rana, N.
    Koley, M.
    Gupta, J.
    Thakrani, D.
    Schultz, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S124 - S124
  • [10] Preclinical Evaluation of [212Pb]VMT-α-NET Targeted Alpha Therapy for High-Risk Metastatic Neuroblastoma
    Liu, D.
    Ewald, J. T.
    Dai, Z.
    Robels-Plannels, C.
    Cagle, B. S.
    Rodman, S. N., III
    Li, M.
    Rastogi, R.
    Sagastume, E.
    Johnson, F. L.
    Zepeda-Orozco, D.
    Schultz, M. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S65 - S65
123